- Round ID
- FR-00294
- Stage
- Series C
- Round name
- Series C
- Amount
- $47M / £37M
Dated funding evidence
Healx
Series C · $47M / £37M · 2024-08-01
Reported round$47M / £37MSeries C
- Disclosure date
- 2024-08-01
- Reported currency
- USD
- Companies House
- 09018507
- Evidence sources
- 4
Company
HealxCH 090185072024-08-01Series C$47M / £37M
Resolved investor records
R42 GroupLead investorAtomicoLead investorBaldertonInvestorJonathan MilnerInvestorGlobal BrainInvestorAyana CapitalInvestoro2h VenturesInvestorVU Venture PartnersInvestor
1 additional source-listed name is retained in the record fields below but not linked without an exact canonical match.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- R42 Group, Atomico
- Other investors
- Balderton, Jonathan Milner, Global Brain, btov, Ayana Capital, o2h Ventures, VU Venture Partners
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.